Table 4.
No-T1D, TG+ (n=71) | No-T1D, TG− (n=70) | P-value | |
---|---|---|---|
Sex (%males) | 27 (38%) | 34 (49%) | 0.21 |
Age (y) | 13.7 ± 3.3 | 14.1 ± 3.1 | 0.50 |
Height z-score | 0.41 ± 1.07 | 0.22 ± 1.20 | 0.33 |
Weight z-score | 0.27 ± 1.05 | 0.17 ± 1.37 | 0.61 |
BMI z-score | 0.08 ± 1.06 | 0.08 ± 1.14 | 0.98 |
Vitamin D 25OH (ng/mL) | 34 ± 8 | 33 ± 9 | 0.44 |
Ferritin (ng/mL) | 34 (29–40) | 35 (30–42) | 0.79 |
Urine N-Telopeptides | 182 (147–224) | 174 (138–220) | 0.79 |
(nmol BCE/mmol creat) | |||
BMD L1-L4 z-score | −0.15 ± 1.08 | −0.04 ± 1.13 | 0.58 |
Low BMD¶ | 3 (4%) | 2 (3%) | 1.0000* |
Symptoms | 25 (36%) | 14 (20%) | 0.038 |
Data are presented as mean ± SD, geometric mean and 95% CI or frequency (%).
Fisher Exact P-value due to cell sizes < 5.
Low BMD defined by BMD L1-L4 z-score (for age and gender) of ≤ −2 SD.